LINCOLNSHIRE, Ill., July 23 /PRNewswire/ -- BioSante Pharmaceuticals, Inc. (Amex: BPA) will present at the following forum: What: BioSante Pharmaceuticals (Amex: BPA) will give a presentation at Informed Investors Biotechnology /Healthcare Virtual Stocks Forum. John McCamant, Editor, The Medical Technology Stock Letter, will deliver the forum keynote address at 9 am. When: July 27, 2004 @ 9:30 AM Eastern Time Where: http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85119 How: Live over the Internet-Simply log on to the web at the address above. Contact: Phillip Donenberg, Chief Financial Officer, firstname.lastname@example.org If you are unable to attend the live event, the forum will be available via webcast at http://www.informedinvestors.com/IIF_Forum.asp?ForumID=85119. BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante's hormone therapy products are gel formulations for transdermal administration that deliver bioidentical estradiol and testosterone. Symptoms treated with hormone therapy in men include impotence, diminished sex drive, muscle weakness and osteoporosis. Symptoms in menopausal women include hot flashes, vaginal atrophy, decreased libido and osteoporosis. The estrogen and testosterone markets in the United States alone account for over $2.5 billion in annual sales. The company also is developing its calcium phosphate nanotechnology (CAP) for novel vaccines, including biodefense vaccines for toxins such as anthrax and ricin, and drug delivery systems. Additional information is available online at http://www.biosantepharma.com. FORUM CONTACT: Cary Loeser, Informed Investors, +1-804-327-3407, email@example.com Web site: http://www.informedinvestors.com
SOURCE Biosante Pharmaceuticals, Inc.